-
Most Popular
Search Results
240 results for COV
Despite Huge Run, There’s Still Some Upside for Novavax
Though RNA vaccines may have jumped to the lead, the complexities of the Covid-19 crisis gives NVAX stock some extra room to run even higher.
Merck Could Be the Covid-19 Investment You’re Missing
Some traders consider Merck stock to be a safe Dow Jones type of investment. Yet, the Covid-19 vaccine angle could propel the share price.
Novavax Can Still Make Coronavirus Vaccines Great Again
While Pfizer and Moderna enjoy first-to-market advantage, the reality is that being first in a vaccine race isn’t always the best. Plus, Novavax’s distinct approach…
Mutual Funds Spotlight – T. Rowe Price Health Science Fund
The T. Rowe Price Health Science Fund is a great example of sector mutual funds for investors looking to play one industry and capitalize on…
The Risk-to-Reward Proposition for Sorrento Has Gone Bad
Sorrento Therapeutics shareholders witnessed SRNE stock gain 70% in the past month. The risk-to-reward proposition has gone from good to bad.
A Healthy Portfolio Is Heavy in Health Care
Investors would be foolish to ignore the massive demographic shift and growth potential that is boosting health care stocks right now.
BioNano Genomics Is in a Perfect Bull-Bear Tug of War
Among all the biotech pivots toward the novel coronavirus, BNGO stock represents one of the most sensible. But does that mean shares are a buy?
Beware: Ocugen Is a Near $2 Billion Company That Has No Revenue
While the market obviously loves Ocugen’s pivot to addressing the Covid-19 pandemic, the reality is that OCGN stock doesn’t come anywhere close to deserving its…
Stocks Come Out Swinging: Monday’s IP Market Recap
Positive news in construction and manufacturing combined with a number of analyst upgrades to help push the broader indices ahead Monday.
Upgrades This Week: BAC, CAT, WAG
Bank of America (BAC), Caterpillar Inc. (CAT) and Walgreen Co. (WAG) were among some of the widely held stocks upgraded by Louis Navellier in his…
Novavax Stock Might Actually Win This War of Attrition
Though Novavax stock is looking like the antithesis of its former self in the first half of this year, the wildness detracts from what could…
Is Inovio Stock Still a Buy After Its Massive 150% Leap This Year?
Inovio is developing a potential vaccine for the coronavirus. If you can handle the volatility, it may be time to buy INO stock.
CODX Stock Pops as Co-Diagnostics Ships Out Monkeypox Tests
CODX stock is up during early afternoon trading as Co-Diagnostics ships out monkeypox testing reagents to help deal with the outbreak.
Stocks Cool as the Middle East Boils
Investors are exhibiting fear that seems to have resulted in paralysis.
Given Imaging – Why Is GIVN Stock Soaring?
Given Imaging just got snatched up by a larger healthcare firm, sending shares of GIVN stock soaring over 26% in this morning’s trading.
Covidien Follows Abbott With a Pharma Spin-Off
Could Sanofi, Novartis or GlaxoSmithKline be next to separate pharmaceutical development into a stand-alone company?
25 Software Stocks to Sell Now
The overall ratings of 25 Software stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…
Novavax (NVAX) Stock Slides Despite Vaccine Availability
Although Novavax’s non-mRNA vaccine being available broadly represents good news, NVAX stock suffered due to unfavorable timing.
NVAX, AI, CVNA: The 3 Most Shorted Stocks This Month
With the market suffering losses due to broader headwinds, hedge funds have targeted the most shorted stocks for cynical profits.
6 – 10 of 240 results
